Mohamad E. Allaf, MD, presented “Novel Imaging for Renal Mass Characterization” during the 43rd Annual Ralph E. Hopkins Urology Seminar on January 31, 2024, in Jackson Hole, Wyoming.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Allaf, Mohamad E. “Novel Imaging for Renal Mass Characterization.” January 31, 2024. Accessed Dec 2024. https://grandroundsinurology.com/novel-imaging-for-renal-mass-characterization/
Novel Imaging for Renal Mass Characterization – Summary
In this 18-minute presentation, Mohammed E. Allaf, MD, discusses novel imaging techniques for renal mass characterization, emphasizing advancements and their clinical implications. He outlines the traditional imaging modalities such as ultrasound, CT, and MRI, which, despite their utility, have limitations that lead to indeterminate findings, necessitating further diagnostic procedures.
Dr. Allaf highlights multiparametric MRI (mpMRI), contrast-enhanced ultrasound (CEUS), and PET imaging as tools in this advanced era of molecular imaging. For example, advancements in PET imaging contribute significantly to the management of renal cell carcinoma, enabling more accurate staging and potentially guiding targeted therapies. He underscores that radiologists, urologists, and oncologists must collaborate to interpret imaging results accurately and develop individualized treatment plans for patients.
About The 43rd Annual Ralph E. Hopkins Urology Seminar:
The Ralph E. Hopkins Urology Seminar is a multi-day meeting focused on training urologists in the latest in assessing, diagnosing, and treating urologic conditions in the clinical setting. Updates are provided on urologic cancers, stone disease, urologic reconstruction, female urology, infertility, sexual function, emerging surgical techniques, and general urology. The 43rd iteration of the meeting took place from January 31st to February 2nd, 2024, in Jackson Hole, Wyoming.
For further educational activities from this conference, visit our collection page.